DNA damage checkpoint activation contributes to the radio-resistance of mouse mesenchymal stromal cells Tara Sugrue, & Rhodri Ceredig Regenerative Medicine Institute Centre for Chromosome Biology National University of ireland, Galway
The DNA Damage Response contributes to MSC radio-resistance
Radiation Response of the Bone Marrow IR Mesenchymal stromal cell Survive (MSC) Die Haematopoietic stem cell (HSC) Haematopoietic failure Rieger K, Marinets O, Fietz T et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cells or bone marrow transplantation. Exp Hematol 2005;33:605-611. Dickhut A, Schwerdtfeger R, Kuklick L et al. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cells transplantation originate from host tissue. Ann Hematol 2005;84:722-727.
Isolation of mouse MSCs CD44 ‘’ Bulk MSCs ’’ CD73 CD90 Heterogenous population. CD105 Sca-1 “CFU-F” Homogenous Mouse MSC line Clonal expansion population
Role of the DNA Damage Response in mediating the radio- resistance of MSCs Mouse mesenchymal stromal Mouse haematopoietic V cell line cell line MS5 ST4.5 CD4 + CD8 + Thymocyte Radio-resistant Radio-sensitive
The DNA Damage Response IR Chromatin DSB Activation of sensor and transducer proteins Signalling to effector proteins Effector Scaffolding Regulatory kinases proteins proteins Cell Cycle Arrest DNA Repair Transcription Apoptosis
Tracking cell cycle progression BrdU G1 S G2 M S G 1 Cell count BrdU G 2 +M S G 2 + M G 1 2n 4n PI DNA content (PI)
MSCs activate IR-induced DNA Damage checkpoints Time post irradiation (10 Gy) 0 hrs 2 hrs 4 hrs 12 hrs S MS5 G 1 G 2 /M ST4.5 BrdU PI 90 % S phase population 80 MS5 Control 70 MS5 10 Gy 60 50 40 30 20 ST4.5 Control 10 ST4.5 10 Gy 0 0 1 2 4 6 8 12 24 36 48 72 Time (Hrs)
MSCs recover from DNA damage checkpoint activaton Time post irradiation (10 Gy) 0 hrs 12 hrs 24 hrs 72 hrs S MS5 G 1 G 2 /M ST4.5 BrdU PI % BrdU labelled G1 population 80 MS5 Control 70 MS5 10 Gy 60 ST4.5 Control 50 40 ST4.5 10 Gy 30 20 10 0 0 1 2 4 6 8 12 24 36 48 72 Time (Hrs)
MSCs suppress IR-induced Apoptosis Time post irradiation (10 Gy) Untreated 2 hrs 4 hrs 12 hrs 36 hrs MS5 ST4.5 PI Annexin V 100 ST4.5 % Annexin V positive cells 80 60 40 20 MS5 0 0 2 4 8 12 24 36 Time post 10 Gy irradiation (Hrs)
Conclusions Ø MSCs survive long-term post high dose γ -irradiation. Ø MSCs activate a robust DNA Damage Response via rapid γ -H2AX formation. Ø MSCs recover from IR-induced DNA damage by: (i) Activating DNA damage checkpoint mechanisms. (ii) Activating DNA DSB repair. (iii) Preventing induction of apoptosis.
Acknowledgements NUI Galway Regenerative Centre for Medicine Institute Chromosome Biology Prof. Rhodri Ceredig Prof. Noel Lowndes Dr. James Brown Genome Stability Prof. Matthew Griffin Laboratory Immunology Group Dr. Michael Rainey Immunology and Transplant Biology Dr. Alessandro Natoni Group Simona Moravcová Michelle Duffy Senthilkumar Alagesan
Internalization, Dimerization, and Activation of CD38 during mNOX Activation:
Logistics The Renderman Shading Language Checkpoint 3 Grading underway
Texture Mapping Logistics Checkpoint 2 Mostly graded. Note on grading --
Paper Summaries Any takers? Procedural Shading Announcement Logistics
This i his is s your br our brain ain on on RADIO RADIO Ca Cate
Compilers Activation Records Alex Aiken Activation Records The information
ICD-10 Checkpoint: Update for NJ-HFMA Jim Hennessy June 2015 e4 Services
Assignments Checkpoint 6 Tone Reproduction Due Monday Another
More UI Output Tasks: Damage Management & Layout Damage management Need
ACTIVATION MARCH 26, 2020 ACTIVATION OF POWER Against COVID-19 ZOOM Room
One-two Punch to Deadly Pancreatic Cancer: Targeted Therapy with Mab AR9.6 and
Novel Therapeutic for Healing Gut Tissue Novel Therapeutic for Healing Gut
Approaches to Identifying Approaches to Identifying Possible Mechanisms of
Structure-function analysis of the inositol trisphosphate receptor and its
Activatable Molecular Probes for Optical Imaging Ick Chan Kwon, Ph.D.
Tomorrow's Innovation: Changing R&D Model in Life Sciences Jim Sullivan,
Comparative effect of Various HDAC-inhibitors in-vitro on T- Cell Lymphoma
How we use animal studies to understand recovery from brain injury Ann M.
Dose-Response Approaches for Nuclear Receptor-Mediated Modes of Action
The Use of Proteomics in Elucidating Mechanisms of Predisposition for Mammary
iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint
Oncopeptides Company presentation October,2019 1 Disclaimer IMPORTANT: You